Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Cell Death Differ ; 18(5): 769-82, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21113145

RESUMEN

Loss of parkin function is responsible for the majority of autosomal recessive parkinsonism. Here, we show that parkin is not only a stress-protective, but also a stress-inducible protein. Both mitochondrial and endoplasmic reticulum (ER) stress induce an increase in parkin-specific mRNA and protein levels. The stress-induced upregulation of parkin is mediated by ATF4, a transcription factor of the unfolded protein response (UPR) that binds to a specific CREB/ATF site within the parkin promoter. Interestingly, c-Jun can bind to the same site, but acts as a transcriptional repressor of parkin gene expression. We also present evidence that mitochondrial damage can induce ER stress, leading to the activation of the UPR, and thereby to an upregulation of parkin expression. Vice versa, ER stress results in mitochondrial damage, which can be prevented by parkin. Notably, the activity of parkin to protect cells from stress-induced cell death is independent of the proteasome, indicating that proteasomal degradation of parkin substrates cannot explain the cytoprotective activity of parkin. Our study supports the notion that parkin has a role in the interorganellar crosstalk between the ER and mitochondria to promote cell survival under stress, suggesting that both ER and mitochondrial stress can contribute to the pathogenesis of Parkinson's disease.


Asunto(s)
Factor de Transcripción Activador 4/metabolismo , Retículo Endoplásmico/fisiología , Mitocondrias/fisiología , Estrés Fisiológico , Ubiquitina-Proteína Ligasas/genética , Secuencia de Bases , Carbonil Cianuro m-Clorofenil Hidrazona/farmacología , Muerte Celular , Línea Celular , Retículo Endoplásmico/efectos de los fármacos , Inhibidores Enzimáticos/efectos adversos , Genes Reporteros , Humanos , Ionóforos/farmacología , Luciferasas de Renilla/biosíntesis , Potencial de la Membrana Mitocondrial , Mitocondrias/efectos de los fármacos , Regiones Promotoras Genéticas , Complejo de la Endopetidasa Proteasomal/fisiología , Proteínas Proto-Oncogénicas c-jun/metabolismo , Interferencia de ARN , Elementos de Respuesta/genética , Transducción de Señal , Tapsigargina/efectos adversos , Transcripción Genética , Ubiquitina-Proteína Ligasas/metabolismo , Respuesta de Proteína Desplegada , Regulación hacia Arriba , eIF-2 Quinasa/metabolismo
2.
Hum Mol Genet ; 19(19): 3734-46, 2010 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-20639397

RESUMEN

Growing evidence highlights a role for mitochondrial dysfunction and oxidative stress as underlying contributors to Parkinson's disease (PD) pathogenesis. DJ-1 (PARK7) is a recently identified recessive familial PD gene. Its loss leads to increased susceptibility of neurons to oxidative stress and death. However, its mechanism of action is not fully understood. Presently, we report that DJ-1 deficiency in cell lines, cultured neurons, mouse brain and lymphoblast cells derived from DJ-1 patients display aberrant mitochondrial morphology. We also show that these DJ-1-dependent mitochondrial defects contribute to oxidative stress-induced sensitivity to cell death since reversal of this fragmented mitochondrial phenotype abrogates neuronal cell death. Reactive oxygen species (ROS) appear to play a critical role in the observed defects, as ROS scavengers rescue the phenotype and mitochondria isolated from DJ-1 deficient animals produce more ROS compared with control. Importantly, the aberrant mitochondrial phenotype can be rescued by the expression of Pink1 and Parkin, two PD-linked genes involved in regulating mitochondrial dynamics and quality control. Finally, we show that DJ-1 deficiency leads to altered autophagy in murine and human cells. Our findings define a mechanism by which the DJ-1-dependent mitochondrial defects contribute to the increased sensitivity to oxidative stress-induced cell death that has been previously reported.


Asunto(s)
Péptidos y Proteínas de Señalización Intracelular/deficiencia , Péptidos y Proteínas de Señalización Intracelular/genética , Mitocondrias/genética , Mitocondrias/patología , Proteínas Oncogénicas/deficiencia , Proteínas Oncogénicas/genética , Enfermedad de Parkinson/genética , Acetilcisteína/farmacología , Animales , Autofagia/efectos de los fármacos , Encéfalo/metabolismo , Encéfalo/patología , Muerte Celular/efectos de los fármacos , Línea Celular , Humanos , Ratones , Mitocondrias/efectos de los fármacos , Mitocondrias/ultraestructura , Proteínas Mutantes/metabolismo , Neostriado/efectos de los fármacos , Neostriado/metabolismo , Neostriado/patología , Neostriado/ultraestructura , Neuronas/efectos de los fármacos , Neuronas/enzimología , Neuronas/patología , Neuronas/ultraestructura , Enfermedad de Parkinson/patología , Peroxirredoxinas , Fenotipo , Proteína Desglicasa DJ-1 , Proteínas Quinasas/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Ubiquitina-Proteína Ligasas/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...